InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (121 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
121
T+90 hit rate
100%
T+90 mean return
+21.0%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Carlyle Group Inc., Board Member. Insider active across 11 companies, notably ZoomInfo Technologies Inc.. Aggregated, 137 filings have been published. Split: 2 buys · 121 sells. Total volume traded: €2.7bn. History available since 6 August 2021. The latest transaction was disclosed on 27 March 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations137 total
29,370,166 shares@ US$27.1673.7% of flowCommon StockSEC:0001641172-25-001770:0
28,438 shares@ US$2.00541.6% of flowCommon StockSEC:0001493152-24-048670:0
3,901 shares@ US$2.02060.2% of flowCommon StockSEC:0000950170-24-132421:0
8,260,183 shares@ US$35.31491.9% of flowCommon StockSEC:0001493152-24-047186:0
250,000 shares@ US$2.32915.9% of flowCommon StockSEC:0000950170-24-115995:0
225,000 shares@ US$2.115212.9% of flowCommon StockSEC:0000950170-24-115328:0
92,905 shares@ US$2.27395.7% of flowCommon StockSEC:0000950170-24-114705:0
924,466 shares@ US$2.143153.4% of flowCommon StockSEC:0000950170-24-114343:0
133,643 shares@ US$2.51199.0% of flowCommon StockSEC:0000950170-24-113762:0
12,849,448 shares@ US$22.7426.3% of flowCommon StockSEC:0000950170-24-113236:0
6,344 shares@ US$40.80640.1% of flowCommon StockSEC:0001493152-24-031632:0
43,184 shares@ US$39.66970.5% of flowCommon StockSEC:0001493152-24-030981:0
4,936,483 shares@ US$0.011.3% of flowCommon StockSEC:0000950170-24-092927:0
400 shares@ US$38.970.0% of flowCommon StockSEC:0001493152-24-030559:0
3,204 shares@ US$39.84030.0% of flowCommon StockSEC:0001493152-24-030260:0
2,205 shares@ US$38.93310.0% of flowCommon StockSEC:0001493152-24-029935:0
39,707 shares@ US$38.75330.5% of flowCommon StockSEC:0001493152-24-029612:0
64,219 shares@ US$39.23340.8% of flowCommon StockSEC:0001493152-24-029612:1
142,269 shares@ US$38.83411.7% of flowCommon StockSEC:0001493152-24-029612:2
15,821 shares@ US$39.02040.2% of flowCommon StockSEC:0001493152-24-029612:3
2,526 shares@ US$37.90420.0% of flowCommon StockSEC:0001493152-24-029244:0
6,202 shares@ US$34.95970.1% of flowCommon StockSEC:0001493152-24-028928:0
53,224 shares@ US$33.45920.5% of flowCommon StockSEC:0001493152-24-028698:0
6,736 shares@ US$31.76210.1% of flowCommon StockSEC:0001493152-24-028341:0
4,722 shares@ US$31.70630.0% of flowCommon StockSEC:0001493152-24-028077:0
25 of 137 declarations
About Carlyle Group Inc.
Public sources do not provide a detailed biographical profile for The Carlyle Group Inc. as a board member, but they do show Carlyle’s ties to the listed companies through ownership and board-designation rights. In QuidelOrtho, a stockholders agreement gives Carlyle Partners VI Cayman Holdings, L.P. the right to designate two directors so long as it holds at least 12% of the common stock, and the 2024 proxy says Messrs. Schmidt and Prutow are Carlyle’s two designated directors. Carlyle also appears in SEC filings for ZoomInfo and StandardAero, and in Jasper Therapeutics materials, but the sources found do not identify a single individual Carlyle director tied to all of these companies. Sources: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000018/qdel-20240402.htm
